Molecular characteristics of multifocal invasive mucinous adenocarcinoma of the lung: Report of a rare case
Authors:
Open Access
- 29 August 2017
- journal article
- Published by Wiley in Thoracic Cancer
- Vol. 8 (6) , 710-713
Abstract
Invasive mucinous adenocarcinoma (IMA) is an uncommon entity in the lung, with a poor prognosis. Multifocal IMA of the lung is even more unusual, and there is little experience with effective treatments. Herein, we present a case of multifocal IMA diagnosed in a 36 year‐old man by video‐assisted thoracoscopic surgery. A right middle lobe and a nodule in the right upper lobe were resected, as were mediastinal lymph nodes, leaving behind an autonomous right lower lobe nodule. To explore the feasibility of molecular treatment, next‐generation sequencing of genetic mutations was performed after four cycles of chemotherapy (pemetrexed + cisplatin). Ultimately, a KIAA 1468‐ RET fusion gene was detected at a disproportionate level (~67.3%), indicating that targeted therapy may be efficacious in treating this disease.Keywords
Funding Information
- Wu Jieping Medical Foundation (320.6750.143 20)
- National Natural Science Foundation of China (81760528)
This publication has 18 references indexed in Scilit:
- Alectinib Shows Potent Antitumor Activity againstRET-Rearranged Non–Small Cell Lung CancerMolecular Cancer Therapeutics, 2014
- Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinomaOncoTargets and Therapy, 2014
- RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysisBritish Journal of Cancer, 2014
- The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterationsLung Cancer, 2013
- Response to Cabozantinib in Patients with RET Fusion-Positive Lung AdenocarcinomasCancer Discovery, 2013
- Validation of the IASLC/ATS/ERS Lung Adenocarcinoma Classification for Prognosis and Association with EGFR and KRAS Gene Mutations: Analysis of 440 Japanese PatientsJournal of Thoracic Oncology, 2013
- RET Fusions Define a Unique Molecular and Clinicopathologic Subtype of Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2012
- RET, ROS1 and ALK fusions in lung cancerNature Medicine, 2012
- KIF5B-RET fusions in lung adenocarcinomaNature Medicine, 2012
- Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinibLung Cancer, 2010